Assessing the Recent Fate of Lifecycle Management Strategies in the U.S. Courts
03/06/2009

Abbott v. Torpharm | Pfizer v. Ranbaxy | Seth Fidel | Apotex v. Merck | Hatch Waxman | lifecycle management strategies
- How does Hatch Waxman impact the implementation of lifecycle strategies?
- Mastering U.S. pharmaceutical patent lifecycle strategies, including dosage forms, delivery systems, polymorphs, formulations, controlled release technologies and isomeric purity
- Analysing the impact of recent case law including Apotex v. Merck (2007), Abbott v. Torpharm (2007) and Pfizer v. Ranbaxy (2006)
For further case law to be discussed in this session please check www.iqpc.com/uk/patentlifecycle.
Dr. Seth Fidel, Executive Director Legal Affairs and Chief IP Counsel, Neurogen Corporation
Abbott v. Torpharm | Pfizer v. Ranbaxy | Seth Fidel | Apotex v. Merck | Hatch Waxman | lifecycle management strategies
-
Balancing Data Privacy Protection and Freedom of Information Act Disclosures with Retention and Other Disclosure Obligations -
Effective Ways to Minimise Costs in Legal Department Operations - Pavel Klimov, General Counsel EMEA, Unisys -
The World of Anti-Trust: Due Diligence with Global Competition Laws -
Corporate Counsel Exchange Video Testimonial -
A Practical Take on e-Discovery and Data Privacy Laws -
Analysing the Technology Available at Every Stage of Litigation -
Adding Value, Increasing Profit and Reducing Cost in your E-Disclosure Practices -
Case Study: Spearheading the Global Roll-Out of a Global E-mail Management and Retention Project -
Maximising the Efficiency of Collaborations and Managing the Impact on your Intellectual Property Rights -
Getting All Stakeholders On-Side: Implementing a Cross-Disciplinary Information Retention Committee
* = required.
Not a member yet? Sign up
Events of Interest





Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!